Vir Biotechnology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell VIR and other ETFs, options, and stocks.About VIR
Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes.
CEOMarianne de Backer
CEOMarianne de Backer
Employees587
Employees587
HeadquartersSan Francisco, California
HeadquartersSan Francisco, California
Founded2016
Founded2016
Employees587
Employees587
VIR Key Statistics
Market cap1.07B
Market cap1.07B
Price-Earnings ratio-1.73
Price-Earnings ratio-1.73
Dividend yield—
Dividend yield—
Average volume805.80K
Average volume805.80K
High today$8.21
High today$8.21
Low today$7.76
Low today$7.76
Open price$7.95
Open price$7.95
Volume1.08M
Volume1.08M
52 Week high$27.48
52 Week high$27.48
52 Week low$7.72
52 Week low$7.72
Analyst ratings
67%
of 9 ratingsBuy
66.7%
Hold
33.3%
Sell
0%